dc.contributor.author | Johnson, MB | |
dc.contributor.author | Flanagan, SE | |
dc.contributor.author | Martins, TB | |
dc.contributor.author | Hill, HR | |
dc.contributor.author | Hattersley, AT | |
dc.contributor.author | McDonald, TJ | |
dc.date.accessioned | 2017-01-31T15:30:39Z | |
dc.date.issued | 2016-11 | |
dc.description.abstract | Letter to the editor | en_GB |
dc.description.sponsorship | This work was supported by the Wellcome Trust. SF has a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 105636/Z/14/Z). | en_GB |
dc.identifier.citation | Vol. 62, pp. 1536 - 1538 | en_GB |
dc.identifier.doi | 10.1373/clinchem.2016.263624 | |
dc.identifier.other | clinchem.2016.263624 | |
dc.identifier.uri | http://hdl.handle.net/10871/25491 | |
dc.language.iso | en | en_GB |
dc.publisher | American Association for Clinical Chemistry | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/27608644 | en_GB |
dc.rights.embargoreason | Publisher policy | en_GB |
dc.title | Low IgE is a useful tool to identify STAT3 gain-of-functionmMutations. | en_GB |
dc.type | Article | en_GB |
dc.identifier.issn | 1530-8561 | |
exeter.place-of-publication | United States | en_GB |
dc.description | This is the author accepted manuscript. The final version is available from the publisher via the DOI in this record. | en_GB |
dc.identifier.journal | Clinical Chemistry | en_GB |
dc.identifier.pmid | 27608644 | |